Women worry about their own health, but are increasingly aware and educated about the health of their spouses, children and parents.

Breast MRI images can help identify tumors in dense breast tissue that might be obscured on traditional mammography.
Breast MRI can be used to screen for cancers in women with dense breast tissue.
Breast MR image showing tumors that were obscured by dense breast issue on a mammogram.

As breast MRI becomes a more widely accepted modality for breast cancer screening of women at high risk, hormone status and menstrual cycle are important imaging considerations.

Atherosclerosis is the leading cause of cardiovascular disease (CAD), heart attacks and death in both men and women in the United States. However, advances in diagnosing and treating coronary artery disease treatment have concentrated on lowering mortality rates in men and less so in women.

Mammography on the Road to Integration

One of the biggest challenges that has plagued mammography radiologists is integrating the stand-alone mammography workstation with the multimodality workstation.

While the war on breast cancer wages on, there are signs that doctors and patients may be on the winning side. Over the past year, we have seen significant advances in diagnosing and treating breast cancer. On the front line, tomosynthesis is in development and has been hailed by the medical community as a promising innovation in the early diagnosis of breast cancer.

September 17, 2009 - Inflation rates for healthcare supplies are projected to remain unchanged through 2010, according to an analysis released by the Premier healthcare alliance.

September 16, 2009 - iCAD Inc. will host a series of educational events designed for radiologists, urologists, oncologists, radiation oncologists, surgeons, technologists and other referring physicians who diagnose and treat patients with prostate cancer.

September 16, 2009 – The Henry Ford Health System (HFHS) in Detroit, Mich., selected Apollo PACS Inc. (Apollo) as the vendor to implement its digital pathology informatics network.

September 17, 2009 - The Senate Finance Committee reduced the imaging utilization assumption rate from 90 percent to 65 percent, in essence cutting the originally proposed utilization increase by nearly two-thirds.

September 17, 2009 - Lantheus Medical Imaging Inc. today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now